CRRX CareRx Corp
- 2.245
- -0.035-1.54%
CareRx Corp News
CareRx Brief: Dalton Will Be Succeeded by Jeff Watson, a Current Independent Director of the Board
CareRx Brief: Company Undertaking a Search for a New CFO; Davide Pernarella, Currently Vice President, Business Planning and Analysis at CareRx, Will Assume the Role of Interim CFO
CareRx Brief: Says Andrew Mok Will Step Down as Chief Financial Officer Effective June 7, 2024, to Pursue Another Employment Opportunity
CareRx Q1 Net Loss Narrows, Revenue Dips
Calendar of Canada Earnings Expected in the Week Ahead
CareRx Corporation to Host First Quarter 2024 Financial Results Conference Call on Friday, May 10, 2024 at 8:30 A.m. ET
CareRX Corp. Is Maintained at Buy by Desjardins Securities
CareRx to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 17, 2024
CareRx Corporation Welcomes Ontario Government's Pause of Planned Fee Changes
CareRx Brief: In Connection With Prior Announced Normal Course Issuer Bid to Buy Up To 1 Million of Its Common Shares, It Has Entered Into an Automatic Share Purchase Plan
Carerx Corp Price Target Cut to C$2.75/Share From C$3.25 by Stifel Nicolaus
CareRx Narrows Q4 Loss, Revenue Falls
CareRx Corporation to Host Fourth Quarter 2023 Financial Results Conference Call on Thursday, March 7, 2024 @ 8:30 A.m. ET
Carerx Corp Price Target Raised to C$3.25/Share From C$2.75 by Cormark Securities
CareRx Brief: Says Closed $70 Million Debt Refinancing
Carerx Corp Price Target Cut to C$2.75/Share From C$4.00 by Cormark Securities
Echelon Wealth Partners Remains a Buy on CareRx (CRRX)
CareRx Plans to Buy Back Shares Through a Normal-Course Issuer Bid
Express News | Carerx Corp Cut to Market Perform From Buy by Cormark Securities
Express News | Carerx Corp Price Target Cut to C$4.00/Share From C$5.00 by Cormark Securities
